BIVDA - The British In Vitro Diagnostics Association > Press Releases

Articles from March 2008

Randox continues to improve diagnostics worldwide (March 2008)

Randox Laboratories is an international clinical diagnostics company, producing approximately 7% of the world’s clinical chemistry products. Innovation is the central focus of this impressive company, with 28% of total annual revenue being reinvested in research

Seventeen Synthetic Steroids in a Single Sample (March 2008)

Randox Laboratories’ new biochip system can screen for 17 synthetic steroids in a single sample. The biochip screens for gestagens and other steroids including trenbolone, boldenone and stanozolol. The Synthetic Steroids Array is an ideal high-throughput screening method, replacing up to 17 individual tests with a single assay.

Detect 10 Drugs of Abuse in one go (March 2008)

Consolidate your drug screening with the Drugs of Abuse biochips from Randox. Drugs of Abuse testing can be costly and time consuming and may not always include all common drugs and their metabolites. There is a need to find rapid and cost-effective methods to screen for Drugs of Abuse.

RX Monza available now (March 2008)

The RX Monza is now available from Randox Laboratories. The RX Monza is a semi-automated clinical analyser ideal for low-throughput testing. The first consignments of RX Monza analysers were delivered to customers in February.

Multi-analyte cytokine testing from Randox (March 2008)

Consolidate your research testing. Newly released cytokine biochip arrays from Randox allow simultaneous detection of up to 12 cytokines, cytokine receptors and growth factors in a single patient sample.

Growth Promoters Biochip Screening Test (March 2008)

Randox Laboratories has produced a biochip screening test for growth promoter drug residues including Beta-Agonists, Corticosteroids, Stilbenes and Ractopamine. The Growth Promoters array from Randox simultaneously and quantitatively performs nine assays on a single sample.